Mark PhD.

Investigator, Protein Sciences at GNF - San Diego, California, US

Mark PhD.'s Colleagues at GNF
Alicia Moten

Senior Patent Paralegal

Contact Alicia Moten

Jeff Tieger

SUPPLY CHAIN MANAGER

Contact Jeff Tieger

Mike Baker

GNF Ceramics process engineer

Contact Mike Baker

Matt Petrus

Scientific Associate II

Contact Matt Petrus

View All Mark PhD.'s Colleagues
Mark PhD.'s Contact Details
HQ
858-812-1500
Location
Company
GNF
Mark PhD.'s Company Details
GNF logo, GNF contact details

GNF

San Diego, California, US • 500 - 999 Employees
BioTech/Drugs

The Genomics Institute of the Novartis Research Foundation (GNF), founded in 1999 and now with over 560 employees, is under the umbrella of the Novartis Institute for Biomedical Research (NIBR) and is affiliated with the Novartis Institute for Developing World Medical Research (NIDWMR). GNF applies integrated state-of-the-art technologies in chemistry, biology, automation, and information sciences in order to pursue new approaches towards the understanding of complex biomedical problems in cancer biology, immunology, neuroscience, and metabolic as well as infectious disease. These technologies cut across the life sciences, and include genomics and proteomics tools, medicinal chemistry, cell-based high throughput screening of genes or compounds, structural genomics, and forward/reverse mammalian genetics.

Biomedical Research Cancer Research Genetic Testing Immunology Drug Development And Manufacturing Proteomics Neurobiology Microbiology Infectious Disease
Details about GNF
Frequently Asked Questions about Mark PhD.
Mark PhD. currently works for GNF.
Mark PhD.'s role at GNF is Investigator, Protein Sciences.
Mark PhD.'s email address is ***@gnf.org. To view Mark PhD.'s full email address, please signup to ConnectPlex.
Mark PhD. works in the BioTech/Drugs industry.
Mark PhD.'s colleagues at GNF are Alicia Moten, Jeff Tieger, Mike Baker, Matt Petrus, Brandon Taylor, De Hall, Glenn Federe and others.
Mark PhD.'s phone number is 858-812-1500
See more information about Mark PhD.